- Modifiers of TGF-beta1 effector function as novel therapeutic targets of pulmonary fibrosis
-
Lee CM, Park JW, Cho WK, Zhou Y, Han B, Yoon PO, Chae J, Elias JA, Lee CG
- KMID: 1792051
- Korean J Intern Med.
- 2014 May;29(3):281-290.
- doi: 10.3904/kjim.2014.29.3.281
Pulmonary fibrosis is a fatal progressive disease with no effective therapy. Transforming growth factor (TGF)-beta1 has long been regarded as a central mediator of tissue fibrosis that involves multiple organs... -
- CITED
-
- Close
- SHARE
-
- Close
- Neostigmine for the Treatment of Acute Hepatic Encephalopathy with Acute Intestinal Pseudo-obstruction in a Cirrhotic Patient
-
Park CH, Joo YE, Kim HS, Choi SK, Rew JS, Kim SJ
- KMID: 1781744
- J Korean Med Sci.
- 2005 Feb;20(1):150-152.
- doi: 10.3346/jkms.2005.20.1.150
We treated a 49-yr-old man with neostigmine, who had liver cirrhosis, acute hepatic encephalopathy, and acute intestinal pseudoobstruction. He was admitted in a state of hepatic confusion. On physical examination,... -
- CITED
-
- Close
- SHARE
-
- Close
